|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010068,
umls-concept:C0036453,
umls-concept:C0085862,
umls-concept:C0914069,
umls-concept:C1257890,
umls-concept:C1299583,
umls-concept:C1522318,
umls-concept:C1549571,
umls-concept:C1608386,
umls-concept:C1705493,
umls-concept:C1706420,
umls-concept:C2698872
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2000-10-19
|
|
pubmed:abstractText |
Chronic inflammation is believed to increase the risk of coronary events by making atherosclerotic plaques in coronary vessels prone to rupture. We examined blood constituents potentially affected by inflammation as predictors of risk in men with hypercholesterolemia who were enrolled in the West of Scotland Coronary Prevention Study, a trial that evaluated the value of pravastatin in the prevention of coronary events.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
pubmed-author:CaslakeM JMJ,
pubmed-author:CooneyJJ,
pubmed-author:FordII,
pubmed-author:KrishnaMM,
pubmed-author:LoweG DGD,
pubmed-author:MacpheeC HCH,
pubmed-author:McMahonA DAD,
pubmed-author:O'ReillyD SDS,
pubmed-author:PackardC JCJ,
pubmed-author:RumleyAA,
pubmed-author:SucklingK EKE,
pubmed-author:WilkinsonF EFE
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
19
|
|
pubmed:volume |
343
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1148-55
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11036120-1-Alkyl-2-acetylglycerophosphocholine Esterase,
pubmed-meshheading:11036120-Anticholesteremic Agents,
pubmed-meshheading:11036120-Biological Markers,
pubmed-meshheading:11036120-C-Reactive Protein,
pubmed-meshheading:11036120-Case-Control Studies,
pubmed-meshheading:11036120-Cholesterol,
pubmed-meshheading:11036120-Coronary Disease,
pubmed-meshheading:11036120-Fibrinogen,
pubmed-meshheading:11036120-Humans,
pubmed-meshheading:11036120-Hypercholesterolemia,
pubmed-meshheading:11036120-Inflammation,
pubmed-meshheading:11036120-Leukocyte Count,
pubmed-meshheading:11036120-Logistic Models,
pubmed-meshheading:11036120-Male,
pubmed-meshheading:11036120-Middle Aged,
pubmed-meshheading:11036120-Myocardial Infarction,
pubmed-meshheading:11036120-Phospholipases A,
pubmed-meshheading:11036120-Phospholipases A2,
pubmed-meshheading:11036120-Pravastatin,
pubmed-meshheading:11036120-Risk Factors,
pubmed-meshheading:11036120-Triglycerides
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.
|
|
pubmed:affiliation |
Department of Pathological Biochemistry, Glasgow Royal Infirmary, Scotland. chris.packard@clinmed.gla.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
